Safety and Tolerability of COVID-19 Vaccine (ABNCoV2)

Clinical trial NCT04839146 · COMPLETED

Trial details

NCT number: NCT04839146
Sponsor: Radboud University Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Covid19 Severe Acute Respiratory Syndrome SARS-CoV-2 Infection

Start date: 2021-03-11
Primary completion: 2021-12-30
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.